Exhaled Breath Pattern After Medication Intake, in OSA Patients, or Other Pulmonary Diseases
Conditions
Brief summary
Identification of exhaled breath pattern of human subjects
Detailed description
Breath analysis with mass spectormetry as a non-invasive method to identfy exhaled breath patterns.
Interventions
OTHERNo intervention
No intervention
Sponsors
University of Zurich
Deep Breath Intelligence (DBI)
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes
Inclusion criteria
* \>= 18 years * Informed consent
Exclusion criteria
* specific
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Exhaled breath pattern | baseline | mass spectrometric profile of exhaled breath pattern of human subjects |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Chemical structure of exhaled breath molecules | baseline | The identification of the chemical structure of exhaled breath molecules |
| Body fluids | baseline | The correlations of identified molecules in exhaled breath with body fluids |
| Disease marker | baseline | The correlation of a distinct disease marker with a breath print or breath feature |
| Distinguish between disease | baseline | The use of a breath print to distinguish between disease and/or health state |
| Health state | baseline | The correlation of breath prints to subjective health state and/or quality of life |
| Medication | baseline | Response to medication and toxicity as a function of blood/breath drug concentrations |
| Excretion of drugs | baseline | Correlation between lung function and the excretion of drugs in exhaled breath |
Countries
Switzerland
Contacts
CONTACTMalcolm Kohler, MD
CONTACTNoriane Sievi, MSc
Outcome results
None listed